PROMATIX BIOSCIENCES LTD

Active London

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PROMATIX BIOSCIENCES LTD

Research and experimental development on biotechnology

Founded 25 Aug 2021 Active London, England 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Apr 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 27 Aug 2025 Next due 7 Sept 2026 3 months remaining
Net assets £-548K £2M 2024 year on year
Total assets £1M £975K 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

78 Pall Mall London SW1Y 5ES England

Website

www.example.com

Full company profile for PROMATIX BIOSCIENCES LTD (13585400), an active life sciences and medical technology company based in London, England. Incorporated 25 Aug 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

N/A

Net Assets

-£548.43k

Decreased by £2.32M (-131%)

Total Liabilities

£1.84M

Increased by £1.34M (+272%)

Turnover

N/A

Employees

6

Increased by 5 (+500%)

Debt Ratio

143%

Increased by 121 (+550%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 8,330 Shares £7500.01m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 May 20244,330£0£0
18 Apr 20233,000£7500.00m£2.50m
25 Apr 20221,000£10k£10

Officers

Officers

3 active
Status
Alek SafarianDirectorAustralianUnited States6125 Aug 2021Active
Graeme Richard MartinDirectorBritishEngland7114 Oct 2024Active
Robert Henry BalfourDirectorBritishEngland4623 Jan 2023Active

Shareholders

Shareholders (6)

Alsa Ventures I Gp S.a R.l Acting On Behalf Of Alsa Ventures I Scsp
71.6%
3,580
Oxford Biotherapeutics Ltd
15.0%
750

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Alek Safarian

Australian

Active
Notified 25 Aug 2021
Residence England
DOB October 1964
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
17 Mar 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
27 Aug 2025Confirmation StatementConfirmation statement made on 24 Aug 2025 with no updates
16 Jun 2025Persons With Significant ControlChange to Mr Alek Safarian as a person with significant control on 6 Apr 2025
16 Jun 2025OfficersChange to director Mr Alek Safarian on 6 Apr 2025
23 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

17 Mar 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

27 Aug 2025 Confirmation Statement

Confirmation statement made on 24 Aug 2025 with no updates

16 Jun 2025 Persons With Significant Control

Change to Mr Alek Safarian as a person with significant control on 6 Apr 2025

16 Jun 2025 Officers

Change to director Mr Alek Safarian on 6 Apr 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 23 Apr 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

1 months ago on 17 Mar 2026

Confirmation statement made on 24 Aug 2025 with no updates

8 months ago on 27 Aug 2025

Change to Mr Alek Safarian as a person with significant control on 6 Apr 2025

11 months ago on 16 Jun 2025

Change to director Mr Alek Safarian on 6 Apr 2025

11 months ago on 16 Jun 2025